美年健康连收4个涨停板

Core Viewpoint - Meinian Health has experienced a significant stock price increase, achieving a limit-up for four consecutive trading days, with a total rise of 46.32% during this period [2] Recent Stock Performance - As of January 13, 2026, the stock price reached 8.15 yuan, with a turnover rate of 0.45% and a trading volume of 17.44 million shares, amounting to a transaction value of 1.42 billion yuan [2] - The stock's limit-up order amount is 18.26 billion yuan, and the total market capitalization of A-shares is 319.01 billion yuan, with a circulating market value of 315.75 billion yuan [2] Margin Trading Data - The latest margin trading balance for Meinian Health is 1.089 billion yuan, with a financing balance of 1.075 billion yuan, reflecting a decrease of 43.43 million yuan or 3.88% from the previous trading day [2] - Over the past four days, the margin trading balance has decreased by a total of 116 million yuan, representing a decline of 9.74% [2] Institutional Activity - The stock has appeared on the Dragon and Tiger list due to a cumulative price deviation of 20% over three consecutive trading days [2] - Institutional investors have net bought 26.05 million yuan, while the total net purchase from the Shenzhen Stock Connect is 42.58 million yuan, with a total net sell of 75.42 million yuan from brokerage seats [2] Company Background - Meinian Health Industry Holdings Co., Ltd. was established on January 22, 1991, with a registered capital of 391.43 million yuan [2]